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Abstract
Background: The physiological background of exercise-induced muscle fatigue(EIMUF) is only poorly understood.
Thus, monitoring of EIMUF by a single or multiple biomarkers(BMs) is under debate.
After a systematic literature review 91 papers were included.
Results: EIMUF is mainly due to depletion of substrates, increased oxidative stress, muscle membrane depolarisation
following potassium depletion, muscle hyperthermia, muscle damage, impaired oxygen supply to the muscle,
activation of an inflammatory response, or impaired calcium-handling. Dehydration, hyperammonemia, mitochondrial
biogenesis, and genetic responses are also discussed. Since EIMUF is dependent on age, sex, degree of fatigue, type,
intensity, and duration of exercise, energy supply during exercise, climate, training status (physical fitness), and health
status, BMs currently available for monitoring EIMUF have limited reliability. Generally, wet, volatile, and dry BMs are
differentiated. Among dry BMs of EIMUF the most promising include power output measures, electrophysiological
measures, cardiologic measures, and questionnaires. Among wet BMs of EIMUF those most applicable include markers
of ATP-metabolism, of oxidative stress, muscle damage, and inflammation. VO2-kinetics are used as a volatile BM.
Conclusions: Though the physiology of EIMUF remains to be fully elucidated, some promising BMs have been recently
introduced, which together with other BMs, could be useful in monitoring EIMUF. The combination of biomarkers
seems to be more efficient than a single biomarker to monitor EIMUF. However, it is essential that efficacy, reliability,
and applicability of each BM candidate is validated in appropriate studies.
Keywords: Biomarker, Biological marker, Muscle fatigue, Monitoring, Muscle exercise, Exercise fatigue, Exhaustion,
Endurance
Background
A biomarker (BM) is a measurable molecule or test, to
objectively monitor the change of a condition or process
over time, after treatment, or after training [1]. BMs may
be used for diagnostic purposes, for monitoring pur-
poses, or for risk assessment [2]. BMs can be used as an
indicator of a biological state, or to objectively assess a
biological or pathological process. To assess the degree
of muscle fatigue (continuous reduction of muscle force
(maximal voluntary contraction (MVC)) during exercise
(exercise-induced muscle fatigue (EIMUF), peripheral fa-
tigue) and the impact of exercise on the skeletal muscle,
various BMs have been proposed but their reliability is
questionable [3]. BMs of EIMUF need to be differentiated
from BMs of physical fitness, muscle damage (injury), of
overtraining, of inflammation, and from BMs of central
fatigue (central nervous system disease) or fatigue due
to systemic disease (anemia, menstruation, malignancy,
cardiac disease, chronic infection, vitamin deficiency,
or hepatopathy). To approach the topic of monitoring
EIMUF it is essential to establish a definition of EIMUF
and to elucidate its physiologic background. Aim of this
review was to describe and discuss established findings and
new aspects emerging from the clinical and experimental
literature about BMs of EIMUF. These new aspects are ex-
pected to influence experimental modelling, development
of diagnostics, and development of new BMs to more ac-
curately monitor EIMUF.
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Method
Data for this review were identified by searches of
MEDLINE, Current Contents, Springerlink, Wiley, EBSCO,
Ovid, and Web of science by applying a sensitive search
strategy using combinations of the following search terms:
“biomarker”, “biological marker”, in combination with “fa-
tigue”, “fatigability”, “muscle”, “exercise”, “exercise-induced”,
and “exhaustion”. Further manual search was conducted to
identify other relevant articles from cross-references. Ran-
domized (blinded or open label) clinical trials, longitudinal
studies, case series, and case reports were considered. Ab-
stracts and reports from meetings and animal studies were
not included. Only articles about humans and published in
English, French, Spanish, or German between 1966 and
2015 were considered. Appropriate papers were studied
and discussed for their suitability to be incorporated in this
review.
Results
Altogether 134 papers were found to be suitable to match
with the intentions of the review. Of these, 91 were se-
lected, because they were available as full papers, they
provided most recent data, they provided an extensive,
in-depth discussion of their results, and they compared
previous findings with the current results.
Biomarkers
Requirements a BM must meet
Not each molecule or test is eligible to serve as an ap-
propriate BM of EIMUF. Requirements a BM must meet
are that the correlation between the measurement and
the represented process is linear, that it shows the con-
tinuous change of the process, and that it appropriately
reflects the outcome of a condition in the sense of a lin-
ear outcome measure. Additionally, BMs must register
quick changes (translational marker) and need to change
as a function of the process being monitored. They need
to be stable without appreciable diurnal variations, need
to correlate significantly with exercise intensity, and need to
be present in detectable amounts in easily accessible bio-
logical fluids [2]. It is also essential that the usefulness and
efficiency of a BM has been validated and proven, not to
unnecessarily increase costs. Generally, BMs need to be
easily collected (easily accessible tissues), cheap, the test
should be easy to perform with widely available equipment,
should be reliable when tested by different examiners and
repeatedly, and independent of age, sex, environmental and
climate conditions, pre-existing training condition, food,
hydration, daytime, and the exercise monitored. It is also
important that the test carried out to monitor EIMUF does
not further induce fatigue. Most of the available BMs of
EIMUF do not meet these requirements [3].
Dependency of a BM
Since there is no ideal BM, BMs depend on various dif-
ferent factors. These include age, sex, degree of general
fatigue, type, intensity, frequency, and duration of exer-
cise (e.g. voluntary or electrical stimulation), type of con-
traction (isometric, isotonic, intermittent, continuous),
environmental climatic conditions (temperature, humid-
ity, wind speed), food, daytime. and physiological and
training status (physical fitness) of an individual [1, 4]. A
BM may also depend on the energy supply during exer-
cise, on hydration, and on the health status (healthy or
diseased individuals) [5]. The optimal choice of a BM is
not only dependent on the factors just mentioned but
also on how good the physiology of the process to be
monitored is understood.
Classification of BMs
BMs can be classified according to the method applied
as wet, volatile, or dry BM [6], as translational or non-
translational BM, as invasive or non-invasive BM, as val-
idated or non-validated BM, or as BM for measuring
focal or generalised EIMUF. Most wet BMs derive from
blood, saliva, or urine. Only rarely other body fluids are
investigated. Most dry BMs are measures of the power
output, cardiac parameters, or scales or questionnaires.
Needle and particularly surface electromyography (EMG)
are also applied for monitoring EIMUF. The choice of a
BM for monitoring EIMUF depends on the duration, type,
and intensity of exercise performed. There is a difference
if the exercise is short-lasting for only a few seconds or
minutes or a long-lasting condition, like in marathon run-
ners or triathloners. It is also strongly dependent on the
type of contraction. BMs can be also categorised according
to the exercise performed, which can be either assessed by
another test or can be the BM itself (Fig. 1). BMs of
EIMUF may be further differentiated into external and in-
ternal BMs. External load quantifying tools include power
output measuring devices, time-motion analysis (to ana-
lyse movement patterns in team-sport), or movement
kinematics or kinetics, whereas internal load quantifying
tools include, for example, cardiac parameters, neuromus-
cular function, biochemical, hormonal, or immunological
assessments, and questionnaires (Table 1) [3].
Classification of exercise
Exercise, carried out to induce fatigue, may be classified
according to various criteria such as duration, intensity,
or type of muscle contraction or according to the type
of energy production (aerobic or anaerobic). According
to duration and intensity, exercise may be classified as
short-duration, low-intensity exercise, as short-duration,
high intensity exercise, or as long-duration exercise.
According to the type of energy production exercise may
be classified as <20 sec in duration (up to 90 % anaerobic
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energy), 20 sec to 1 min (aerobic and anaerobic energy),
and exercise lasting >1 min (>50 % aerobic energy). It is
essential to know that exercise may not induce fatigue
if exercise is mild and carried out for a very short time.
Exercise may be also classified as static (no movement
of entire body) or as dynamic (movement of entire body
(e.g. sport)) [7]. Exercise may be carried out within an ex-
perimental setting (e.g. standardised ergometer (simu-
lated)) or as an open-air exercise (running, walking (real))
[8]. Muscle contraction during exercise may be voluntary
or stimulated, continuous or discontinuous, or isometric
(no change of length), isotonic (muscle length changes)
which can be either eccentric or concentric, or isokinetic
(like isotonic but with constant speed).
Exercise-induced muscle fatigue (EIMUF)
EIMUF is a complex and multimodal process involving
various metabolic and functional mechanisms.
Definition of EIMUF
Due to the uncertainties about the complex nature of
EIMUF a number of different definitions exist depending
on the underlying experimental model or the conditions
under which EIMUF develops [3]. One of the most com-
monly applied definitions of fatigue describes EIMUF as
“a failure to maintain the required or expected muscle
force” (reduced power output (work rate), ATP turnover
rate) [9]. In this definition fatigue is regarded as decrement
of power production (decline of muscle force, decreased
force output) and EIMUF corresponds to the reduction of
muscle force during exercise [10, 11]. Another popular and
more general definition of EIMUF defines it as “inability to
complete a task that was once achievable within a recent
time frame” [3]. Exercise scientists define EIMUF as
“exercise-induced impairment of muscle performance”
[10]. Exercise intensity is initially sustained by recruitment
of new motor units and help from synergistic muscles
[10]. As exercise proceeds, technique and motor skill
execution deviates to maintain outcomes but lastly they
deteriorate resulting in reduced accuracy and velocity
[10]. EIMUF may be also defined as divergence between
external load (work completed by a subject and mea-
sured independently of its internal characteristics) and
internal load (relative physiological or psychological
stress imposed) [3]. A combination of both may be
Fig. 1 General test arrangement to monitor EIMUF. Monitoring tests
may be generally carried out before and after the test (usually for
dynamic exercise) or continuously during the entire test (usually for
static exercise)
Table 1 BMs of EIMUF currently under discussion
Dry BMs
Power output
Measurement of muscle force
Counter movement jump
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important for monitoring EIMUF [3]. An example for
an external load is the power output sustained for a
given duration. Examples for internal loads are the heart
rate or perception of the effort [3]. Compensatory mecha-
nisms of fatigue are an altered CNS muscle recruitment
pattern, recruitment of additional motor units, syn-
chronisation of firing frequencies, and increase of firing
frequencies. Fatigue may be physiologic or pathologic. It
may last for a short while or for days (e.g. 6 days in soccer
players after a match) [12]. Fatigue is dependent of simi-
lar factors as described for BMs [3].
Physiology of muscle fatigue
To understand and monitor EIMUF it is essential to in-
clude all physiological aspects of EIMUF. Currently, how-
ever, the physiology of EIMUF is not fully understood
because it is difficult to investigate an active muscle and
because several processes run off simultaneously during
any type of muscle exercise [13]. Thus, it is essential for
future studies to find out which changes and processes
contribute most to EIMUF. Presumably responsible for
EIMUF are a shortage of substrates to maintain contrac-
tion, such as carbohydrates, calcium, sodium, potassium,
or ATP, continuous oxidative stress, electrophysiological
changes due to decrease of membrane depolarisation,
hyperthermia, muscle damage, inflammatory processes,
calcium-handling, and impaired oxygen supply (hypoxia)
of the contracting muscle [14, 15].
Depletion of carbohydrate deposits During a marathon
there is progressive depletion of carbohydrate reservoirs
(glucose deposits in the liver and muscle) due to the ac-
tive muscle [14, 16]. Insufficient supply of carbohydrates
during a marathon can lead to hypoglycemia and con-
secutively muscle fatigue [17]. In addition to carbohy-
drates other essential metabolites, such as ascorbic acid,
calcium, sodium, potassium, and ATP may be depleted
during exercise [7]. Depletion of ATP may be associated
with an increase in ADP, which inhibits sodium/potas-
sium ATPases and calcium-ATPases [18].
Production of reactive oxygen species (ROS) Exercise
induces excessive production of ROS leading to oxida-
tive stress, fatigue and reduced exercise performance
[19, 20]. Oxidative stress is highest immediately after
exercise but may rise again hours after finishing exercise
[2]. Accordingly, oxidative stress parameters are typically
increased immediately after exercise [21]. Oxidative stress
in form of ROS is implicated in the damage of various
macromolecules, immune dysfunction, and muscle dam-
age [19]. Oxidative stress may not only be responsible for
EIMUF but also for impaired recovery from exercise [22].
Membrane depolarisation due to potassium depletion
During high-intensity, long-term exercise potassium is
continuously leaking from the muscle cell decreasing the
membrane potential and thus depolarising the muscle
membrane, therefore currents cannot propagate along
the membrane or get into the triad [23]. Consecutively,
the muscle becomes weak [1, 24]. Additionally, depletion
of potassium from muscle cells results in progressive
hyperkalemia with increasing exercise intensity [25].
Hyperthermia Particularly after long-duration exercise
hyperthermia (exertional heat illness, core temperature >39°)
develops, reducing muscle performance [14, 21]. Inter-
estingly, those with high post-exercise core temperature
maintain a steady pace throughout the exercise while
those with a lower post-exercise core temperature show
lower pace at the end of the run [14]. Thus, post-race
temperature correlates positively with mean running
pace [14]. This could be due to increased muscle dam-
age among those with low pace and thus lower core
temperature [14].
Muscle damage Muscle damage is another factor con-
tributing to muscle fatigue during endurance activity. In
a study of 25 triathlon participants there was a positive
correlation between reduced muscle performance and
blood markers of muscle damage, such as creatine-kinase
(CK), lactate-dehydrogenase (LDH), or myoglobin [26].
This study further showed that there is a relation between
muscle damage and fatigue [26]. Accordingly, mara-
thoners with higher levels of running fatigue, develop
higher levels of CK, LDH, and myoglobin compared to
marathoners with low levels of running fatigue [14]. An-
other study found a positive correlation between post-race
urinary myoglobin concentration, an indirect marker of
muscle damage, and the decrease of muscle performance
after a marathon [27]. When performing muscle biopsy
before and after a marathon, it has been evidenced that a
marathon produces muscle fiber necrosis and inflamma-
tion [28]. These morphological alterations are similar to
those found in rhabdomyolysis [28]. These findings
suggest that muscle fatigue, particularly during endur-
ance exercise, may partly derive from muscle damage.
Muscle damage is one of the most relevant sources of
EIMUF in long-distance runners [26].
Cardiac stress Cardiac stress as measured by the cardiac
stress index (CSI), using a non-linear, detrended fluctuation
analysis (DFA) of the heart rate, was positively correlated
with the Borg rating perceived exertion (RPE) scale suggest-
ing that cardiac stress contributes to EIMUF [29]. Since the
CSI effectively quantifies the degree of cardiac stress during
exercise, it can be used to monitor the cardiac condition
during physical exercise [29]. Additionally, it has been
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shown in Sprague–Dawley rats that heart failure speeds up
the microvascular pO2 mean response time (blood-muscle
O2 driving gradient) [30]. Conversely, in the soleus muscle
of rats low microvascular pO2 reduces the blood-muscle
O2 driving gradient [30].
Inflammation Inflammatory processes are induced during
exercise as a result of muscle metabolism and muscle dam-
age [22]. Muscle biopsy from participants after a marathon
showed muscle fiber necrosis and inflammation [28].
Classical BMs of inflammation are the blood leukocytes,
C-reactive protein, interleukines, and serum or salivary
cortisol [22].
Calcium handling There are some indications that im-
paired calcium handling contributes to the development
of EIMUF [31]. Sarcalumenin is a Ca-binding protein of
the sarcoplasmatic reticulum in muscle cells [31]. Sarca-
lumenin knock-out mice have an enhanced fatigue re-
sistance [31], suggesting that the expression of the gene
is involved in the muscle fatigue mechanism.
Mitochondrial dynamics Excessive exercise increases
the muscle atrophy marker atrogin-1 and MuRF-1 mRNA,
which is accompanied by increased autophagy and fission
of mitochondria in muscle cells [13]. Excessive exercise
also decreases peroxisome proliferator-activated receptor
(PPAR)-γ coactivator PGC-1alpha and complex-I expres-
sion. Furthermore, excessive exercise activates JNK and
Erh1/2 pathways resulting in induction of p53, p21, and
MnSOD expression [13]. These changes in mitochondrial
dynamic remodelling may be responsible for muscle dam-
age and damage of immune functions via downregulation
of mitochondrial biogenesis and upregulation of autoph-
agy [13].
Other potential mechanisms of EIMUF Other poten-
tial factors contributing to the development of EIMUF
may be depletion of muscle proteins into the blood [32],
reduction of blood and plasma volume (dehydration) as
occurring after a marathon [14], acidosis, accumulation
of ammonia, elevated serotonin, hypoxia, hyperkalemia,
or changes of the genetic profile, particularly in long-
duration exercise [10]. For example, EIMUF and reduced
endurance may be due to reduced expression of the
transcriptional coactivator PPAR-α (PGC-α), of which
ectopic expression results in increased number and func-
tion of mitochondria and increase in oxidative, fatigue-re-
sistant muscle fibers [33]. In patients with chronic
obstructive lung disease (COPD) accumulation of plasma
ammonia under conditions of metabolic stress during ex-
ercise contributes to muscle fatigue, independent of the
ventilatory limitation [34]. In a study of tumour suppres-
sor factor p53 knock-out mice it has been shown that p53
initiates mitochondrial biogenesis in response to contract-
ile muscle activity [35].
Postactivation potentiation (PAP)
When discussing peak-force loss after exhaustion it is
important to include the phenomenon of PAP [36]. PAP
is characterised by enhancement of exercise performance
and maintenance of power output after exercise [36, 37].
The physiologic background of PAP is poorly under-
stood. In a study of 22 endurance-athletes undergoing
the University of Montreal track test (UMTT), counter-
movement jump (CMJ) height improved, peak-power
incremented, and athletes maintained their 20 m sprint
performance after exhaustion [36]. In athletes who did
not develop PAP, reduction of peak-force, vertical stiff-
ness, and higher vertical displacement of the center of
mass correlated with serum lactate levels [36]. PAP can
be also observed after other types of exercise, such as
rebound throws [37].
Biomarkers of EIMUF
Studying BMs of EIMUF requires performance of a
defined exercise and measurement of parameters (BMs)
originating from various different mechanisms of EIMUF.
Measurement of BMs may be carried out before, during
or after exercise (Fig. 1). Parameters of interest may
originate from easily accessible body fluids (wet BMs)
or from measuring muscle force, speed of exercise,
electrophysiological recordings, cardiac recordings, kin-
esiology and kinetics, myo-mechanogram (MMG), or
from questionnaires (dry BMs). Measuring VO2 max
and VO2 kinetics during exercise provides the basis for
volatile BMs of EIMUF. Not each putative BM of EIMUF
can be applied to each type of exercise.
Dry biomarkers
Dry BMs are least invasive and thus usually the ones
most easily determined. Dry BMs include measurement
of muscle force (power output) before and after or
during a workload, analysis of electrophysiological re-
cordings, assessment of cardiac parameters, and scales
or questionnaires.
Power output There are various test assemblies to
perform exercise and to assess power output from this
workload to determine muscle fatigue.
Direct measurement of muscle force. Measuring
muscle force before and after predefined workload is
one of the most frequently applied means to measure
EIMUF. Loss of power output during exercise may re-
flect muscle fatigue. Muscle force before and after a
given task can be measured in a single muscle, in a
group of muscles, or in all muscles. Measuring muscle
force may be carried out with dynamometers, power
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output measuring devices (probes), clinical assessment
of muscle force, or more globally with questionnaires.
Various power output measuring devices are available.
Various types of exercise may precede force measure-
ment [3]. Leg and arm force production is reduced after
any exercise but particularly after a marathon [14]. Max-
imum isometric force-generating capacity (MIFGC) is
reduced immediately after eccentric contraction [38].
MIFGC remains depressed 48 h after exercise [38]. Ex-
ternal/internal rotation isokinetic torque [39] is reduced
after exercise, Power output is also reduced after fa-
tiguing leg press exercise [40]. In this test, power is calcu-
lated as the instantaneous product of displacement
velocity and applied force, whereas work output is calcu-
lated as vertical displacement of the weight plates times
applied force [40]. Even peak power, however, may show
diurnal fluctuations with higher values in the evening
compared to the morning [21]. Force of bulbar muscles in
children can be assessed by means of the slurp test [41].
Tongue pressure. An example of assessing power out-
put of bulbar muscles is by measuring the tongue
pressure. In neuromuscular disorders with bulbar in-
volvement, such as myasthenia, amyotrophic lateral
sclerosis (ALS), bulbo-spinal muscular atrophy (SBMA),
oculopharyngeal muscular dystrophy (OPMD), myotonic
dystrophy type 1 (MD1), or mitochondrial disorders
(MIDs), assessment of bulbar functions is mandatory. In
a study of 47 patients with SBMA tongue pressure was
measured by means of an intra-aortic pressure probe and
questionnaires which assessed swallowing [42]. Tongue
pressure was reduced in SBMA patients within 3y after dis-
ease onset. Tongue pressure was reduced even in patients
without dysphagia and repetition of swallowing compen-
sated for tongue weakness in these patients [42]. Tongue
pressure was positively correlated with bulbar-related func-
tional scales [42]. Tongue pressure more strongly corre-
lated with muscle strength of the pharyngeal, neck, and
upper limb muscles than with lower limb muscles.
Though tongue pressure is not validated as a BM of focal
EIMUF, it appears a promising monitor of focal EIMUF
and weakness of bulbar muscles since power output can
be measured over time before and after exercise and cor-
relates well with scales assessing swallowing [42].
Jumping. A further possibility to assess the power out-
put is by means of jumping tests. Most frequently ap-
plied is the CMJ test which collects and analysis
parameters such as mean power, peak velocity, peak
force (PF), peak power (PP), peak torque, jump height,
flight time, contact time, and rate of force development
(RFD) [3, 43, 44]. The test induces only a minimal
amount of additional fatigue itself and thus is useful to
monitor EIMUF when carried out before and after exer-
cise [3, 45]. After an isokinetic, concentric exercise peak
torque and RFD decreased even 24 h after exercise [43].
Jumping performance seems to deteriorate for as long as
72 h post-exercise whereas strength remains unchanged
after an acute bout of intense polymetric exercise [46].
Other jumping tests for measuring the power output in-
clude the static jump (SJ) test [46], the vertical jump test
[47], and the drop jump [47].
Cycling. Another possibility to assess the power output
is by means of cycling on an ergometer. Most commonly
applied is the cycle ergometer sprint test which specific-
ally quantifies the concentric component of the fatigue-
induced decrement of force production in muscle, which
may be overlooked by the CMJ test [48]. The cycle
ergometer sprint test is a method of monitoring EIMUF in
endurance or power-team-sport athletes [48].
Walking. Walking test represent a frequently applied
means to assess the power output. Examples of walking
tests are the 6 m walking test, the 400 m walking speed
test, the timed-up-and-go test [49], the 12-min self-paced
walking test, and stair climbing [49].
Running. Another possibility to assess the power out-
put is by measuring running speed or distance. Reduction
of running speed is a simple means of indirectly measur-
ing EIMUF but only a global parameter since assess-
ment may also include central fatigue. Decrease of
running speed can be particularly observed in long-
distance runners (marathoners) [14]. In a study of 22
endurance athletes carrying out the UMTT, the max-
imum running speed test remained unchanged after the
UMTT, possibly due to PAP [36]. Other running tests
include the maximum running speed over a distance of
20 m (20 m sprint test) [36, 47], the total high-intensity
running distance (THIR) [45], and the repeated sprint
ability (RSA) exercise [50]. Most of the power output
tests show diurnal fluctuations with higher values in
the afternoon compared to the morning [50].
Electrophysiological BMs Surface EMG analysis. Ap-
plying surface-EMG, an interference pattern is recorded
by bipolar surface electrodes positioned over the end-
plate zone of the muscle of interest [51]. Signals are then
passed to an A/D converter, are band-pass filtered, and
converted to root mean square (RMS) or mean rectified
voltage for EMG amplitude, which is roughly equivalent
to the mean rectified value (MRV). Additionally, surface
EMG interference patterns may be analysed by fast Fou-
rier transformation for median frequency, mean power
output, or mean frequency (MF) over a distinct epoch
[8, 52]. In a study of 12 healthy males performing stan-
dardised exercise with two different loadings on a knee
extension device, post-loading EMG-amplitude was either
reduced or increased depending on the type of loading [8].
MRV or RMS are typically increased after exercise. MF
and mean power output are typically reduced after exer-
cise [8]. Muscle fatigue is thus characterised by an increase
Finsterer and Drory BMC Musculoskeletal Disorders  (2016) 17:40 Page 6 of 13
in the EMG interference-pattern amplitude (recruitment
of additional motor units, increase in firing frequency,
synchronisation of discharges) and a shift of the spectrum
to the left [53, 54]. Recovery from muscle fatigue is char-
acterised by a decrease of the EMG-amplitude and a shift
of the spectrum to the right [53].
Muscle torque. To assess muscle torque, muscle stimu-
lation is performed on the resting muscle via self-
adhesive surface electrodes by delivering single rectangular
pulses by a constant-current stimulator to the supplying
nerve until a torque plateau is observed [8]. Antagonist
muscles are not stimulated. The parameters of interest in-
clude the maximum isometric torque, the maximum
twitch torque (peak torque), and the half-relaxation time
[8]. After exercise the peak torque is typically reduced
using variable resistance loadings [8]. Reduction of max-
imum twitch torque is more pronounced in young as
compared to old subjects [8].
M-wave duration. A further electrophysiological
method to monitor EIMUF is the assessment of the M-
wave after stimulation of motor nerves. Stimulation elec-
trodes (cathodes) are placed such that a weak stimula-
tion current gives the strongest response [8]. Then the
stimulating current is increased in 10 mA steps until a
clear plateau in the M-wave amplitude is reached.
Thereafter an additional 25 % of stimulation current is
applied (supramaximal stimulation) [8]. In a study of 12
healthy males performing standardised exercise on a
knee extension device, post-loading peak-to-peak M-
wave duration was significantly increased while area and
amplitude were decreased after the bout [8].
Conduction velocity. In some studies EIMUF resulted
in reduction of the nerve conduction velocity, irrespective
if the proband carried out eccentric or concentric exercise
[55]. In power athletes as well as in endurance athletes the
degree of EIMUF correlated negatively with the nerve
conduction velocity [52]. Other studies, however, did
not confirm these findings [56]. Contrary to nerve con-
duction velocity, muscle fiber conduction velocity (MFCV)
as assessed by surface EMG decreased with EIMUF at
least during dynamic exercise [23, 57, 58]. During static
exercise by means of fatiguing isometric contractions, on
the contrary, MFCV remained unchanged [58].
Transcranial magnetic stimulation (TMS). In 8 pa-
tients with electrical injury undergoing a 2 min exercise
with MVC, TMS revealed prolongation of the silent
period and an increase of the area and amplitude of the
M-wave response [59]. These effects could be increased
if patients were exposed to muscle ischemia induced by
a blood pressure cuff to simulate EIMUF [59]. The
technique allows differentiation between the central and
peripheral contribution to EIMUF [59].
EMG fatigue threshold. The EMG fatigue threshold is
defined as the exercise intensity an individual can
maintain indefinitely without the need to recruit add-
itional motor units, which is associated with an increase
in the amplitude of the interference pattern [60]. Re-
cently, a new practical and reliable method to determine
the EMG fatigue threshold has been introduced [60].
The physical working capacity at fatigue threshold
(PWCFT) is defined as average of the highest power out-
put that results in a non-significant slope coefficient for
the EMG amplitude vs. time relationship and the lowest
power output that results in a significant positive slope
coefficient [61]. Short term exercise increases the fatigue
threshold [62]. By means of the PWCFT heavy from se-
vere domains of exercise intensity can be differentiated
[63]. Helpful in this respect are also the power output
associated with the gas exchange threshold (PGET), the
respiratory compensation point (PRCP), and the critical
power [64, 65]. Usually, aerobic exercise training at
PWCFT is carried out as a task to produce EIMUF [66].
The absent correlation between PWCFT, PGET, and
MPFFT suggests that different physiological mechanisms
underlie these three fatigue thresholds [65].
Cardiac parameters. EIMUF is dependent on the mus-
cular blood flow and thus on cardiac function, therefore
monitoring and evaluation of basic cardiac parameters
can be helpful for assessing EIMUF. Frequently applied
cardiac parameters include the heart rate, the post-
exercise heart-rate recovery (HRR, rate at which heart
rate declines after exercise) [3, 45], and the heart rate
variability (LnrMSSD) calculated from the long-term
ECG [3, 45]. Heart rate is one of the most common pa-
rameters to assess the internal load during exercise [3].
This is because of the linear relationship between heart
rate and oxygen consumption during steady state exer-
cise [3]. Since there is a positive correlation between
THIR, rating of perceived fatigue, and CMJ, HRR and
LnrMSSD are promising candidates for non-invasive
BMs of the fatigue status in elite soccer players [45].
Movement kinematics and kinetics. Parameters of move-
ment kinematics or kinetics correlated with changes in the
muscle fatigue state as measured by EMG interference pat-
tern [67, 68]. Knee and ankle kinematics can be recorded via
optical motion capture [11, 69]. For example, kinematics
and kinetics during a CMJ or drop jump can be measured
by means of a 9 camera motion analysis system (VICON,
100Hz) and a force plate [47] or the Motion Analysis Cor-
poration 3D kinematic analysis system (200Hz) [37]. Evalu-
ated parameters of movement kinematics (jump height,
maximal vertical ground reaction force, reactivity strength
index, lower limb joint work) may serve as BMs of EIMUF
[47]. Other parameters of kinematic measurements by
means of motion tracking systems include the mean and
variability of joint angles, joint torque, and joint net move-
ments for the shoulder, elbow, and wrist [69]. These param-
eters usually decrease during fatigue. Increased kinematic
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variability may be found in the more proximal muscles and
decreased kinematic variability in the more distal muscles
[69]. Kinematic and kinetic adaptations during fatigue are
regarded as reactions to reduce biomechanical loading [69].
Myo-mechanogram (MMG). A further tool to monitor
EIMUF is the MMG, which measures the parameters
peak torque, contraction time, relaxation time, the accel-
eration force development and relaxation, the slope and
tau of force relaxation, and the mean power frequency
fatigue threshold [65, 70]. Peak torque, acceleration of
force development, acceleration of relaxation, slope of
force relaxation and tau of force relaxation decrease during
EIMUF, while contraction time, relaxation time, and the
tau of force relaxation increase [70].
Muscle imaging. Functional analysis of muscles can be
easily carried out by ultrasound. Particularly muscle
fatigue of the diaphragm can be easily monitored by
non-invasive ultrasound. A more elaborate method to
monitor muscle fatigue is phosphorus magnetic resonance
spectroscopy.
Scales and questionnaires. Numerous scores assessing
fatigue during or after exercise are available. A major
disadvantage of most of these scores is that the CNS
component of muscle fatigue is included in the overall
assessment of the performance decline after exercise.
Further disadvantages are that they rely on subjective
information and that many of these scales and ques-
tionnaires are not validated for the different types of
exercise. Scores most frequently used to assess EIMUF
are the perceived rating of fatigue scale [45], the Borg
rating perceived exertion (RPE) scale [3], and the session
rating of RPE (RPE multiplied by exercise duration).
Others include the delayed-onset muscle soreness proto-
col, the delayed onset muscle soreness (DOMS) score
[43], and the Wingate test using the fatigue index [21].
Disadvantage of the RPE is that it shows diurnal fluctua-
tions with higher values at 17.00 h compared to 7.00 h
[50]. A further disadvantage of the RPE is that it is in-
creased during submaximal tasks due to compensatory
higher central and peripheral inputs [10]. Additionally,
physical and subjective changes in performance are less
severe in real sport activities as compared to simulated ac-
tivity [10]. Other dry BMs could be psychomotor speed,
monitoring of sleep quality, or the training impulse
(TRIMP) [3].
Wet biomarkers
Most of the wet BMs of EIMUF derive from blood and
only some from the saliva or urine. The most well-known
wet BMs are those originating from ATP depletion, from
oxidative stress, from muscle damage, or from immuno-
logical compromise [71]. A new candidate of wet BMs is
the C-terminal agrin fragment. Recently, it became feasible
to measure wet BMs directly in the saliva of probands by
application of mass spectroscopy [72].
ATP metabolism Depletion of ATP or increase of adeno-
sine diphosphate (ADP) may contribute to EIMUF [2]. The
most well-known BMs of EIMUF originating from ATP
metabolism include lactate, ammonia, and oxipurines [2].
Lactate. In case the oxidative phosphorylation fails to
provide enough ATP for physiologic requirements,
generation of ATP shifts from aerobic processes to anaer-
obic glycolysis or glycogenolysis [73]. A side product of
the anaerobic pathway is lactate. Lactate linearly increases
with increasing exercise [8]. However, this linear relation
is only maintained below the lactate threshold of about
4 mmol/l [74]. Lactate threshold is defined as percentage
of maximal workload at which lactate increases above nor-
mal. Fatigue develops not earlier than above the lactate
threshold due to exponential increase of lactate above
4 mmol/l. A disadvantage of serum lactate is that the rela-
tion between fatigue and serum lactate becomes non-
linear above the lactate threshold [74]. Further limitations
of lactate measurement are that it depends on the ambient
temperature, hydration status, diet, lactate clearance rate,
glycogen content, previous exercise, and the amount of
muscle mass involved in a given exercise [3]. In a study of
12 endurance athletes and 6 power athletes performing fa-
tiguing isokinetic knee flexions/extensions, serum lactate
increased with fatigue [52]. Lactate also increased during
fatiguing leg press exercise [39]. In a study of 12 healthy
subjects, on the contrary, serum lactate decreased after
core stabilisation exercise, suggesting that lactate clearance
was improved under this condition [75].
Oxipurines (hypoxanthine, xanthine). Oxipurines derive
from the degradation of purine nucleotides (adenine,
guanine). Oxipurines increase with exercise and are
positively correlated with ATP consumption [2]. Oxi-
purines are a specific and sensitive BM of muscle-cell
energy exhaustion during strenuous physical exercise [76].
In a study of 20 healthy males performing isokinetic exer-
cise in a concentric-concentric mode, plasma concentra-
tions of hypoxanthine increased at the end of the exercise
[77]. Thus, hypoxanthine was proposed to serve as a BM
of work-load effectiveness and of metabolic stress conse-
quences in the muscle [77].
Ammonia. The production of ammonia is triggered by
shortage of ATP. In this case, ATP is produced from fusion
of two ADPs resulting in one ATP and one AMP. Ammo-
nia originates from the degradation of AMP to IMP and
ammonia [2]. Serum ammonia depends on sex. Ammonia
increases after short and long duration exercise [2].
Increased oxidative stress BMs of oxidative stress may
reflect an increased production of ROS or a decrease of
the anti-oxidative capacity. Increased production of ROS
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results in increased lipid peroxidation or increased pro-
tein oxidation. The most well-known BM reflecting lipid
peroxidation is TBARS. The most well-known BMs
reflecting decreased antioxidative capacity include gluta-
thione (GSH) and total antioxidant capacity (TAC).
Thiobarbituric acid reactive substances (TBARS). TBARS
are endproducts of lipid peroxidation, which react with
thiobarbituric acid to form a fluorescent red adduct [2, 20].
TBARS are indicators of lipid peroxidation and oxidative
stress [2]. TBARS increase with age, physical fitness,
and are lower in females as compared to males [2].
TBARS increase 5 min after starting an incremental
cycling exercise but increase also 2 days after exercise with
maximal strength attributed to macrophage infiltration-
and xanthine-oxidase activation-triggered reperfusion of
the ischemic muscle [2]. Increase of TBARS during ex-
ercise is accompanied by reduced heat shock protein
(HSP) production, suggesting that oxidative stress during
exercise results from insufficient production of HSP [78].
Glutathione (GSH). GSH is present in nearly all cells
but can be also found in blood and the saliva [2]. GSH is
one of the most important physiological antioxidants but
has other functions as well [20]. As an antioxidant GSH
substitutes halogen-, sulphate-, sulphonate-, phosphate- or
nitrate groups. GSH levels decrease with age and are
higher in females as compared to males. GSH decreases
during high-volume training in healthy subjects, which is
correlated with a drop in performance. The maximal
decrease of GSH during exercise can be observed ap-
proximately 5 min after starting exercising [2].
Increased oxidative stress TAC comprises the entire
pool of specific and non-specific antioxidants within a cell
[20]. TAC includes anti-oxidative enzymes (glutathione
peroxidase (GPX), catalase, superoxide dismutase (SOD)),
non-specific antioxidants (GSH, ascorbic acid, albumin,
uric acid, tocopheroles, carotinoids, coenzyme-Q, biliru-
bine, and the amino acids cysteine, methionine, tyrosine),
and metal chelates. TAC is age- and sex-dependent. TAC
is higher in the morning compared to the afternoon [50].
TAC usually decreases during exercise.
Other oxidative stress BMs. Other potential BMs of oxi-
dative stress include catalase [20], protein carbonyls, SOD,
isoprostanes, malondialdehyde, uric acid, total bilirubine,
and GPX. They have been described in detail elsewhere [2].
A disadvantage of most oxidative stress BMs is that they
show diurnal fluctuations with lower values in the evening
compared to the morning [50]. Antioxidant parameters at
rest are higher in the morning as compared to the evening
[21]. Antioxidative efficiency decreases with age and
damage from oxidative stress increases with age [71].
Inflammatory response It is well appreciated that par-
ticularly long-duration exercise triggers an inflammatory
response in the fatiguing muscle. The most frequently
applied BMs of this inflammatory response include the
leukocyte count, cortisol, and interleukin-6 (IL-6).
Leukocytes. After a marathon, the leukocyte count is
increased by 163 %, the thrombocyte count by 20 % and
the erythrocyte count by 2.1 % [14]. However, a study on
the leukocyte response to bench stepping (high stress)
and to repeated eccentric muscle action (low stress) 4,
24, 48, and 72 h after exercise and by assessing perceived
muscle soreness by means of the delayed-onset muscle
soreness score showed that systemic stress elicited dur-
ing an acute bout of eccentric exercise has a stronger in-
fluence on the functional leukocyte response than the
degree of muscle damage induced [79].
Cortisol. Cortisol levels increase after various types of
exercise. Salivary free cortisol increases in middle and
long-distance runners after the race [80]. Salivary free
cortisol correlates negatively with CMJ height after
middle-distance run [80].
Interleukin-6 (IL-6). IL-6 is secreted by T-lymphocytes
and macrophages to stimulate the immune response after
trauma or other tissue damage, leading to inflammation
[2]. IL-6 also functions as a myokine, such that it increases
in response to muscle contraction [81, 82]. IL-6 mobilises
substrates, increases uptake of glucose, hepatic glucose
production during exercise, insulin-mediated glucose dis-
posal or lipolysis, and fat oxidation [2]. IL-6 is higher in fe-
males as compared to males. IL-6 increases exponentially
with exercise. IL-6 is released to the circulation shortly
after onset of exercise, precedes the appearance of other
cytokines, peaks immediately after exercise, and returns to
normal within a few hours after the bout [83]. IL-6 corre-
lates with duration, intensity, number of active muscles,
and endurance capacity [2].
Other inflammatory BMs. Other potential inflammatory
markers to monitor EIMUF include C-reactive protein [46],
TNF-alpha, and other interleukines (e.g. IL-1b, IL-10).
Muscle damage BMs of muscle damage include serum
CK, LDH and myoglobin. Additionally, myoglobin can
be determined in the urine. These BMs are particularly
increased after middle- or long-duration exercise, and
are hardly useful for monitoring short-duration exercise.
CK and LDH remain increased even 24–72 h after 4 sets
of 10 repetition maximum loads for the chest press, pull-
over, biceps curl, triceps extension, leg extension, and prone
leg curl [84]. Neuromuscular function is also compromised
for up to 48 h after a Rugby match as evidenced by de-
creased peak RFD, PP, and PF on the CMJ [44]. CK in-
creased 30 min after a rugby match with a maximum 24 h
later and remaining elevated for 120 h [44]. BMs of muscle
damage show diurnal fluctuations with higher values in the
evening compared to the morning [50]. Damage to muscle
tissue after a Rugby League match persists for at least 5 days
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post-match [44]. Disadvantage of CK is that the temporal
relationship with muscle recovery is poor [3].
C-terminal agrin fragment (CAF) Agrin is a protein of
the neuromuscular junction. Its activity is regulated by
neurotrypsin, which cleaves it into the C-terminal agrin
fragment (CAF). If there is excessive neurotrypsin activ-
ity degeneration of the neuromuscular junction and thus
decreased power output ensues [61]. In a study of 22
healthy older subjects the CAF was determined from
blood [61]. Additionally, EMG-signals were recorded at
PWCFT during a 2 min discontinuous incremental cycle
ergometer exercise [85, 86]. Recorded EMG signals were
converted as RMS. In men there was a negative correl-
ation between CAF and PWCFT [61]. It was concluded
that CAF concentrations are related to onset of muscle
fatigue (only in men) irrespective of age and BMI [61].
Other potential wet BMs Other potential BMs for moni-
toring EIMUF include testosterone, salivary immunoglobulin-
A, natural killer cell activity, neutrophil phagocytic activity,
methyl-histidine, glucose-1-phosphate, glucose-6-phosphate,
and taurine, of which some can be easily measured in
the saliva by means of capillary electrophoresis and
time-of-flight mass spectroscopy (CE-TOFMS) [46, 72].
Volatile BMs
To sustain endurance performance of the muscle the
ability to deliver oxygen to the muscle and the ability of
the muscle to utilise a given oxygen load for a sustained
period of time (respiratory exchange rate) are important
[87]. Maximal oxygen uptake (VO2 max) as measured
by breath-by-breath open-circuit spirometry is thus a
well-established parameter to assess muscle performance
[88]. VO2 max decreases with EIMUF but decreases also
during age [89]. VO2 max is defined as highest VO2 value
when at least 2 of 3 criteria are met: 1. a plateau of the
heart rate or a heart rate within 10 % of the age-predicted
maximal heart rate, 2. A plateau of VO2, or 3. A respira-
tory exchange rate >1 [88]. Ventilatory threshold is de-
fined as intersection of 2 regression lines (VE and VO2)
[88]. Recently, it has been proposed that slow VO2 kinetics
should be regarded as a volatile BM of exercise intolerance
[90]. Slow VO2 kinetics after exercise is correlated with
greater PCr decrease in the cytoplasm [90]. Conversely,
small PCr decrease is strictly correlated with fast VO2 kin-
etics [90]. Putative volatile BMs of EIMUF other than VO2
could be the VCO2, and the respiratory exchange ratio.
Combinations of BMs
Two or more wet BMs may be combined or two or
more dry BMs may be combined for monitoring EIMUF.
It is also possible to mix wet, volatile, and dry BMs in a
variable ratio of components.
Real-time fatigue monitoring system Recently, a real-
time fatigue monitoring system has been introduced which
quantifies EIMUF during cycling at a constant speed of 60
RPM [91]. The system was equipped with a fatigue progres-
sion measure, which synchronously recorded surface EMG
signals of the lateral vastus and gastrocnemius muscles in
one leg as well as cycling speed in a real-time mode [91].
Additionally, cycling velocity, cycling time, kinesiological
data, heart rate and Borg RPE scale values were taken each
minute [91]. From these measures the fatigue progression
measure was calculated to measure onset-time and pro-
gression of EIMUF [91]. The online fatigue monitoring sys-
tem was validated in healthy subjects and met the intended
purposes.
Fatiguing leg press exercise Static fatiguing leg press
exercise until exhaustion resulted in increased blood lac-
tate and increased MRV of the agonist and antagonist
muscles [39]. Simultaneously, mean power output and
MF of surface-EMG decreased in agonist and antagonist
muscles [39]. Shift to lower frequencies, increase of
MRV, and accumulation of lactate were regarded as in-
dependent BMs of fatigue [39].
Discussion
This review shows that there is progress in the develop-
ment of BMs to monitor EIMUF, that there are different
types of EIMUF depending on the individual, type, in-
tensity, and duration of exercise, and the environmental
conditions, that there is a huge number of putative wet,
volatile, and dry BMs to monitor EIMUF, and that there
is controversy if a single BM or multiple BMs are more
suitable for monitoring EIMUF [1]. This review also
shows that EIMUF is due to different simultaneously ac-
tive mechanisms and that the amount of contribution of
these different mechanisms changes with type, intensity,
and duration of exercise. The choice of a particular BM
may additionally be influenced by sex, ethnicity, climate,
and daytime. Additionally, only few BMs have strong sci-
entific evidence supporting their use, and there is yet to be
a single definite BM of EIMUF described in the literature
[3]. A single definite tool of BMs that is accurate and reli-
able is not currently evident [3]. Currently, there is no
gold standard for monitoring the various physiological al-
terations arising in the skeletal muscle during EIMUF.
This is why we recommend to analyse several BMs simul-
taneously and to further evaluate known BMs and to
search intensively for new BMs. Future work should be
particularly directed towards the question which combin-
ation of BMs is most suitable to monitor EIMUF from a
specific type of exercise in a specific group of probands.
Disadvantages of most BMs currently available are that
appropriate reference limits are available only for a single
given task and that BMs are frequently not validated in
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general and particularly for other tasks. Since reference
limits for BMs for physically active subjects or athletes are
lacking, there is a need to establish such reference limits
adapted to different types of exercise [1]. Each BM needs
to be validated for each type of exercise, to find out which
pattern of BMs is most suitable for monitoring EIMUF
during or after a particular exercise mode. Additionally,
the effectivity of a particular BM for monitoring muscle fa-
tigue needs to be investigated and validated for all types of
exercise. If a BM is sufficiently validated, it can be used for
monitoring performance and progress in training, identify-
ing overtraining, health-related aspects, which can be
modified by regular physical activity, or the physiological
response to exercise in healthy and diseased subjects, pro-
fessional athletes, or amateur athletes. In sport medicine
BMs may be helpful to identify subjects who are at an
increased risk of poor adaptation to training.
The choice of BMs for monitoring EIMUF is much
dependent on the type of exercise to be monitored. Static
exercise allows applying more complex and invasive BMs
also directly during the workout whereas dynamic exercise
allows only determining and monitoring online core
temperature, heart rate, and speed. EIMUF from dynamic
exercise can be more easily monitored by tests carried out
before and after the workload. As an example, electro-
physiological techniques are hardly applicable during dy-
namic exercise and remain the domain of static exercise
induced fatigue. Wet BMs also remain the domain of
static exercise with determination before and after the
bout since measurement during dynamic exercise is only
possible by interrupting the task for collecting the tissue
of interest. The most intensively investigated and most
frequently applied BMs of EIMUF are wet BMs, which
include markers of ATP depletion, oxidative stress, of
muscle damage, and inflammatory markers. Increasingly
investigated are also dry BMs since they are usually more
easily obtained and less invasive. Other factors that deter-
mine which BMs should be used in a specific study de-
rive from the examiner’s end ( availability of special
equipment , the expertise of the researchers in using it,
how time-consuming the technique is) and from the
examined individuals’ end ( ability to perform a specific
task with a specific disease or in a specific age group).
Conclusions
This review shows that some well-known BMs are avail-
able and promising BMs have been recently introduced
to monitor EIMUF although the pathophysiology of
EIMUF remains to be elucidated. To apply a single BM
or a combination of BMs for monitoring EIMUF it is es-
sential that their reliability and applicability is validated
in appropriate studies on healthy and diseased, trained
and untrained, old and young subjects using all different
types of exercise. Currently, it appears that a combination
of BMs reflects the various different fatigue mechanisms
during a certain exercise more adequately than a single
BM. The most appropriate sets of BMs for a given task,
however, remain to be ascertained and to achieve scientific
legitimacy.
Abbreviations
ADP: Adenosin-diphosphate; ALS: Amyotrophic lateral sclerosis;
AMP: Adenosin-monophosphate; ATP: Adenosin-triphosphate; BM: Biomarker;
CAF: C-terminal agrin fragment; CE-TOFMS: Capillary electrophoresis and
time-of-flight mass spectroscopy; CK: Creatine-kinase; CMJ: Counter-
movement jump; CNS: Central nervous system; COPD: Chronic obstructive
pulmonary disease; CSI: Cardiac stress index; DFA: Detrended fluctuation
analysis; DOMS: Delayed onset muscle soreness; EIMUF: Exercise-induced
muscle fatigue; EMG: Electromyography; GPX: Glutathione peroxidase;
GSH: Glutathione; HRR: Heart-rate recovery; HSP: Heat shock protein;
IL: Interleukine; IMP: Inosine monophosphate; LDH: Lactate dehydrogenase;
LnrMSSD: Heart rate variability; MD1: Myotonic dystrophy 1; MF: Mean
frequency; MFCV: Muscle fiber conduction velocity; MID: Mitochondrial
disorder; MIFGC: Maximum isometric force-generating capacity; MMG: Myo-
mechanogram; MRV: Mean rectified voltage; MVC: Maximal voluntary
contraction; OPMD: Oculo-pharyngeal muscular dystrophy;
PAP: Postactivation potentiation; PF: Peak force; PGC: Transcriptional
coactivator peroxisome-proliferator-activated receptor alpha; PGET: Power
output associated with the gas exchange threshold; PP: Peak power;
PPAR: Peroxisome proliferator-activated receptor; PRCP: Respiratory
compensation point; PRF: Perceived rating of fatigue; PWCFT: Physical
working capacity at fatigue threshold; RFD: Rate of force development;
RMS: Root mean square; ROS: Reactive oxygen species; RPE: Rating perceived
exertions; RSA: Repeated sprint ability; SBMA: Spino-bulbar muscular atrophy;
SOD: Superoxide dismutase; TAC: Total antioxidant capacity;
TBARS: Thiobarbituric acid reactive substances; THIR: Total high-intensity run-
ning distance; TMS: Transcranial magnetic stimulation; TRIMP: Training
impulse; UMTT: University of Montreal track test.
Competing interests
The authors declare that they have no competing interests.
Authors’ contribution
JF conceptualised and designed the review and drafted the manuscript.
VD participated in the design and coordination and helped to draft the
manuscript. Both authors read and approved the final manuscript.
Author details
1Krankenanstalt Rudolfstiftung, Postfach 20, 1180 Vienna, Austria. 2Medical
Center, Tel-Aviv, Israel.
Received: 8 October 2015 Accepted: 5 January 2016
References
1. Palacios G, Pedrero-Chamizo R, Palacios N, Maroto-Sánchez B, Aznar S,
González-Gross M, et al. Biomarkers of physical activity and exercise. Nutr
Hosp. 2015;31 Suppl 3:237–44.
2. Finsterer J. Biomarkers of peripheral muscle fatigue during exercise.
BMC Musculoskeletal Dis. 2012;13:218. http://www.biomedcentral.com/
1471-2474/13/218.
3. Halson SL. Monitoring training load to understand fatigue in athletes. Sports
Med. 2014;44 suppl 2:S139–47. doi:10.1007/s40279-014-0253-z.
4. Skurvydas A, Streckis V, Mickeviciene D, Kamandulis S, Stanislovaitis A,
Mamkus G. Effect of age on metabolic fatigue and on indirect symptoms of
skeletal muscle damage after stretch-shortening exercise. J Sports Med Phys
Fitness. 2006;46:431–41.
5. Sawka MN, Burke LM, Eichner ER, Maughan RJ, Montain SJ, Stachenfeld NS,
et al. American College of Sports Medicine position stand. Exercise and fluid
replacement. Med Sci Sports Exerc. 2007;39:377–90.
6. Pennuto M, Greensmith L, Pradat PF, Sorarù G; European SBMA Consortium.
210th ENMC International Workshop: Research and clinical management of
patients with spinal and bulbar muscular atrophy, 27–29 March, 2015,
Finsterer and Drory BMC Musculoskeletal Disorders  (2016) 17:40 Page 11 of 13
Naarden, The Netherlands. Neuromuscul Disord. 2015. doi:10.1016/j.nmd.
2015.06.462.
7. Steinberg JG, Delliaux S, Jammes Y. Reliability of different blood indices to
explore the oxidative stress in response to maximal cycling and static
exercises. Clin Physiol Funct Imaging. 2006;26:106–12.
8. Walker S, Peltonen H, Avela J, Häkkinen K. Neuromuscular fatigue in young
and older men using constant or variable resistance. Eur J Appl Physiol.
2013;113:1069–79.
9. Edwards RHT. Biochemical basis of fatigue in exercise performance.
Champaign: Human Kinetics; 1983.
10. Knicker AJ, Renshaw I, Oldham AR, Cairns SP. Interactive processes link the
multiple symptoms of fatigue in sport competition. Sports Med. 2011;41:307–28.
11. Nessler JA, Huynh H, McDougal M. A single bout of resistance exercise does
not affect nonlinear dynamics of lower extremity kinematics during
treadmill walking. Gait Posture. 2011;34:285–7.
12. Garvican LA, Hammond K, Varley MC, Gore CJ, Billaut F, Aughey RJ. Lower
running performance and exacerbated fatigue in soccer played at 1600 m.
Int J Sports Physiol Perform. 2014;9:397–404.
13. Feng Z, Bai L, Yan J, Li Y, Shen W, Wang Y, et al. Mitochondrial dynamic
remodeling in strenuous exercise-induced muscle and mitochondrial
dysfunction: regulatory effects of hydroxytyrosol. Free Radic Biol Med.
2011;50:1437–46.
14. Abián-Vicen J, Salinero JJ, González-Millán C, Areces F, Ruiz D, Gallo C, et al.
Running pace decrease during a marathon is positively related to blood
markers of muscle damage. PLoS One. 2013;8:e57602. doi:10.1371/journal.
pone.0057602.
15. Rzanny R, Grassme R, Reichenbach JR, Scholle HC, Kaiser WA. Investigations
of back muscle fatigue by simultaneous 31P MRS and surface EMG
measurements. Biomed Tech (Berl). 2006;51:305–13.
16. Sherman WM, Costill DL, Fink WJ, Hagerman FC, Armstrong LE, Murray TF. Effect
of a 42.2-km footrace and subsequent rest or exercise on muscle glycogen and
enzymes. J Appl Physiol Respir Environ Exerc Physiol. 1983;55:1219–24.
17. Callow M, Morton A, Guppy M. Marathon fatigue: the role of plasma fatty
acids, muscle glycogen and blood glucose. Eur J Appl Physiol Occup
Physiol. 1986;55:654–61.
18. Vissing J, Haller RG. Mechanisms of exertional fatigue in muscle
glycogenoses. Neuromuscul Disord. 2012;22 suppl 3:S168–71.
19. Samaras A, Tsarouhas K, Paschalidis E, Giamouzis G, Triposkiadis F,
Tsitsimpikou C, et al. Effect of a special carbohydrate-protein bar and
tomato juice supplementation on oxidative stress markers and vascular
endothelial dynamics in ultra-marathon runners. Food Chem Toxicol. 2014;
69:231–6. doi:10.1016/j.fct.2014.03.029.
20. Kerasioti E, Kiskini A, Veskoukis A, Jamurtas A, Tsitsimpikou C, Tsatsakis AM,
et al. Effect of a special carbohydrate-protein cake on oxidative stress markers
after exhaustive cycling in humans. Food Chem Toxicol. 2012;50:2805–10.
21. Hammouda O, Chtourou H, Chahed H, Ferchichi S, Chaouachi A, Kallel C, et
al. High intensity exercise affects diurnal variation of some biological
markers in trained subjects. Int J Sports Med. 2012;33:886–91.
22. Peake JM, Suzuki K, Coombes JS. The influence of antioxidant
supplementation on markers of inflammation and the relationship to
oxidative stress after exercise. J Nutr Biochem. 2007;18:357–71.
23. Zwarts MJ, Bleijenberg G, van Engelen BG. Clinical neurophysiology of
fatigue. Clin Neurophysiol. 2008;119:2–10.
24. Fortune E, Lowery MM. Effect of extracellular potassium accumulation on
muscle fiber conduction velocity: a simulation study. Ann Biomed Eng.
2009;37:2105–17.
25. Wasserman K, Stringer WW, Casaburi R, Zhang YY. Mechanism of the exercise
hyperkalemia: an alternate hypothesis. J Appl Physiol. 1997;83:631–43.
26. Del Coso J, González-Millán C, Salinero JJ, Abián-Vicén J, Soriano L, Garde S,
et al. Muscle damage and its relationship with muscle fatigue during a half-
iron triathlon. PLoS One. 2012;7(8):e43280. doi:10.1371/journal.pone.0043280.
27. Del Coso J, Salinero JJ, Abián-Vicen J, González-Millán C, Garde S, Vega P, et
al. Influence of body mass loss and myoglobinuria on the development of
muscle fatigue after a marathon in a warm environment. Appl Physiol Nutr
Metab. 2013;38:286–91.
28. Hikida RS, Staron RS, Hagerman FC, Sherman WM, Costill DL. Muscle fiber
necrosis associated with human marathon runners. J Neurol Sci. 1983;59:
185–203.
29. Chen SW, Liaw JW, Chang YJ, Chan HL, Chiu LY. A cycling movement based
system for real-time muscle fatigue and cardiac stress monitoring and
analysis. PLoS One. 2015;10(6):e0130798. doi:10.1371/journal.pone.0130798.
30. Behnke BJ, Delp MD, McDonough P, Spier SA, Poole DC, Musch TI. Effects of
chronic heart failure on microvascular oxygen exchange dynamics in
muscles of contrasting fiber type. Cardiovasc Res. 2004;61:325–32.
31. Zhao X, Yoshida M, Brotto L, Takeshima H, Weisleder N, Hirata Y, et al.
Enhanced resistance to fatigue and altered calcium handling properties of
sarcalumenin knockout mice. Physiol Genomics. 2005;23:72–8.
32. Schiff HB, MacSearraigh ET, Kallmeyer JC. Myoglobinuria, rhabdomyolysis
and marathon running. Q J Med. 1978;47:463–72.
33. Handschin C, Chin S, Li P, Liu F, Maratos-Flier E, Lebrasseur NK, et al. Skeletal
muscle fiber-type switching, exercise intolerance, and myopathy in PGC-
1alpha muscle-specific knock-out animals. J Biol Chem. 2007;282:30014–21.
34. Calvert LD, Steiner MC, Morgan MD, Singh SJ. Plasma ammonia response to
incremental cycling and walking tests in COPD. Respir Med. 2010;104:675–81.
35. Saleem A, Adhihetty PJ, Hood DA. Role of p53 in mitochondrial biogenesis
and apoptosis in skeletal muscle. Physiol Genomics. 2009;37:58–66.
36. Boullosa DA, Tuimil JL, Alegre LM, Iglesias E, Lusquiños F. Concurrent
fatigue and potentiation in endurance athletes. Int J Sports Physiol
Perform. 2011;6:82–93.
37. Harrison AJ. Throwing and catching movements exhibit post-activation
potentiation effects following fatigue. Sports Biomech. 2011;10:185–96.
38. Carson RG, Riek S, Shahbazpour N. Central and peripheral mediation of
human force sensation following eccentric or concentric contractions.
J Physiol. 2002;539:913–25.
39. Detanico D, Dal Pupo J, Franchini E, Dos Santos SG. Effects of successive
judo matches on fatigue and muscle damage markers. J Strength Cond Res.
2015;29:1010–6.
40. Gorostiaga EM, Navarro-Amézqueta I, González-Izal M, Malanda A, Granados
C, Ibáñez J, et al. Blood lactate and sEMG at different knee angles during
fatiguing leg press exercise. Eur J Appl Physiol. 2012;112:1349–58.
41. Hudspeth MP, Holden KR, Crawford TO. The “slurp” test: bedside evaluation
of bulbar muscle fatigue. Pediatrics. 2006;118:e530–3.
42. Mano T, Katsuno M, Banno H, Suzuki K, Suga N, Hashizume A, et al. Tongue
pressure as a novel biomarker of spinal and bulbar muscular atrophy.
Neurology. 2014;82:255–62.
43. Molina R, Denadai BS. Dissociated time course recovery between rate of
force development and peak torque after eccentric exercise. Clin Physiol
Funct Imaging. 2012;32:179–84.
44. McLellan CP, Lovell DI, Gass GC. Markers of postmatch fatigue in
professional Rugby League players. J Strength Cond Res. 2011;25:1030–9.
45. Thorpe RT, Strudwick AJ, Buchheit M, Atkinson G, Drust B, Gregson W.
Monitoring fatigue during the in-season competitive phase in elite soccer
players. Int J Sports Physiol Perform. 2015;(in press).
46. Chatzinikolaou A, Fatouros IG, Gourgoulis V, Avloniti A, Jamurtas AZ,
Nikolaidis MG, et al. Time course of changes in performance and
inflammatory responses after acute plyometric exercise. J Strength Cond
Res. 2010;24:1389–98.
47. Strutzenberger G, Moore J, Griffiths H, Schwameder H, Irwin G. Effects of
gluteal kinesio-taping on performance with respect to fatigue in rugby
players. Eur J Sport Sci. 2015;3:1–7.
48. Wehbe G, Gabett TJ, Dwyer D, McLellan C, Coad S. Monitoring neuromuscular
fatigue in team-sport athletes using a cycle-ergometer test. Int J Sports Physiol
Perform. 2015;10:292–7. doi:10.1123/ijspp.2014-0217.
49. Storer TW, Woodhouse L, Magliano L, Singh AB, Dzekov C, Dzekov J, et al.
Changes in muscle mass, muscle strength, and power but not physical
function are related to testosterone dose in healthy older men. J Am Geriatr
Soc. 2008;56:1991–9.
50. Hammouda O, Chtourou H, Chahed H, Ferchichi S, Kallel C, Miled A, et al.
Diurnal variations of plasma homocysteine, total antioxidant status, and
biological markers of muscle injury during repeated sprint: effect on performance
and muscle fatigue–a pilot study. Chronobiol Int. 2011;28:958–67.
51. Hermens HJ, Freriks B, Merletti R, Stegeman D, Blok J, Rau G, et al. European
recommendations for surface electromyography, results of the SENIAM project
1999. Enschede: Roessingh Research and Development; 1999. p. 44–6.
52. Rainoldi A, Gazzoni M, Merletti R, Minetto MA. Mechanical and EMG responses
of the vastus lateralis and changes in biochemical variables to isokinetic
exercise in endurance and power athletes. J Sports Sci. 2008;26:321–31.
53. Cifrek M, Medved V, Tonković S, Ostojić S. Surface EMG based muscle fatigue
evaluation in biomechanics. Clin Biomech (Bristol, Avon). 2009;24:327–40.
54. Pereira GR, de Oliveira LF, Nadal J. Isometric fatigue patterns in time and
time-frequency domains of triceps surae muscle in different knee positions.
J Electromyogr Kinesiol. 2011;21:572–8.
Finsterer and Drory BMC Musculoskeletal Disorders  (2016) 17:40 Page 12 of 13
55. Gonzalez-Izal M, Lusa Cadore E, Izquierdo M. Muscle conduction velocity,
surface electromyography variables, and echo intensity during concentric
and eccentric fatigue. Muscle Nerve. 2014;49:389–97.
56. Beck TW, Ye X, Wages NP. Local muscle endurance is associated with
fatigue-based changes in electromyographic spectral properties, but not
with conduction velocity. J Electromyogr Kinesiol. 2015;25:451–6.
57. Stewart D, Farina D, Shen C, Macaluso A. Muscle fibre conduction velocity
during a 30-s Wingate anaerobic test. J Electromyogr Kinesiol. 2011;21:418–22.
58. Schmitz JP, van Dijk JP, Hilbers PA, Nicolay K, Jeneson JA, Stegeman DF.
Unchanged muscle fiber conduction velocity relates to mild acidosis during
exhaustive bicycling. Eur J Appl Physiol. 2012;112:1593–602.
59. Kashigar A, Udupa K, Fish J, Chen R. Neurophysiological assessment of
fatigue in electrical injury patients. Exp Brain Res. 2014;232:1013–23.
60. Galen SS, Guffey DR, Coburn JW, Malek MH. Determining the
electromyographic fatigue threshold following a single visit exercise test. J
Vis Exp. 2015;(101). doi:10.3791/52729.
61. Stout JR, Fragala MS, Hoffman JR, Robinson 4th EH, Mccormack WP,
Townsend JR, et al. C-terminal agrin fragment is inversely related to
neuromuscular fatigue in older men. Muscle Nerve. 2015;51:132–3.
62. Emerson NS, Stout JR, Fukuda DH, Robinson EH, Iv STC, Beyer KS, et al.
Resistance training improves capacity to delay neuromuscular fatigue in
older adults. Arch Gerontol Geriatr. 2015;61:27–32.
63. Camic CL, Kovacs AJ, Enquist EA, VanDusseldorp TA, Hill EC, Calantoni AM,
et al. An electromyographic-based test for estimating neuromuscular fatigue
during incremental treadmill running. Physiol Meas. 2014;35:2401–13.
64. Bergstrom HC, Housh TJ, Cochrane KC, Jenkins ND, Lewis RW, Traylor DA, et
al. An examination of neuromuscular and metabolic fatigue thresholds.
Physiol Meas. 2013;34:1253–67.
65. Zuniga JM, Housh TJ, Camic CL, Hendrix CR, Schmidt RJ, Mielke M, et al. A
mechanomyographic fatigue threshold test for cycling. Int J Sports Med.
2010;31:636–43.
66. Jenkins ND, Buckner SL, Baker RB, Bergstrom HC, Cochrane KC, Weir JP, et al.
Effects of 6 weeks of aerobic exercise combined with conjugated linoleic
acid on the physical working capacity at fatigue threshold. J Strength Cond
Res. 2014;28:2127–35.
67. Dingwell JB, Joubert JE, Diefenthaeler F, Trinity JD. Changes in muscle
activity and kinematics of highly trained cyclists during fatigue. IEEE Trans
Biomed Eng. 2008;55:2666–74.
68. Song M, Segala DB, Dingwell JB, Chelidze D. Slow-time changes in human
EMG muscle fatigue states are fully represented in movement kinematics.
J Biomech Eng. 2009;131:021004. doi:10.1115/1.3005177.
69. Qin J, Lin JH, Faber GS, Buchholz B, Xu X. Upper extremity kinematic and
kinetic adaptations during a fatiguing repetitive task. J Electromyogr
Kinesiol. 2014;24:404–11.
70. Cè E, Rampichini S, Limonta E, Esposito F. Torque and mechanomyogram
correlations during muscle relaxation: effects of fatigue and time-course of
recovery. J Electromyogr Kinesiol. 2013;23:1295–303.
71. Bouzid MA, Hammouda O, Matran R, Robin S, Fabre C. Changes in oxidative
stress markers and biological markers of muscle injury with aging at rest
and in response to an exhaustive exercise. PLoS One. 2014;9(3):e90420.
doi:10.1371/journal.pone.0090420.eCollection2014.
72. Ra SG, Maeda S, Higashino R, Imai T, Miyakawa S. Metabolomics of salivary
fatigue markers in soccer players after consecutive games. Appl Physiol Nutr
Metab. 2014;39:1120–6.
73. Gosker HR, Schols AM. Fatigued muscles in COPD but no finishing line in
sight. Eur Respir J. 2008;31:693–4.
74. Siciliano G, Pasquali L, Manca ML, Del Corona A, Tessa A, Patrono C, et al.
The relationship between anaerobic lactate threshold and plasma
catecholamines during incremental exercise in hereditary spastic paraplegia.
Funct Neurol. 2003;18:83–7.
75. Navalta JW, Hrncir SP. Core stabilization exercises enhance lactate clearance
following high-intensity exercise. J Strength Cond Res. 2007;21:1305–9.
76. Bianchi GP, Grossi G, Bargossi AM. May peripheral and central fatigue be
correlated? Can we monitor them by means of clinical laboratory tools?
J Sports Med Phys Fitness. 1997;37:194–9.
77. Speranza L, Grilli A, Patruno A, Franceschelli S, Felzani G, Pesce M, et al.
Plasmatic markers of muscular stress in isokinetic exercise. J Biol Regul
Homeost Agents. 2007;21:21–9.
78. Jammes Y, Steinberg JG, Delliaux S, Brégeon F. Chronic fatigue syndrome
combines increased exercise-induced oxidative stress and reduced cytokine
and Hsp responses. J Intern Med. 2009;266:196–206.
79. Saxton JM, Claxton D, Winter E, Pockley AG. Peripheral blood leucocyte
functional responses to acute eccentric exercise in humans are influenced
by systemic stress, but not by exercise-induced muscle damage. Clin Sci
(Lond). 2003;104:69–77.
80. Balsalobre-Fernández C, Tejero-González CM, del Campo-Vecino J. Relationships
between training load, salivary cortisol responses and performance during season
training in middle and long distance runners. PLoS One. 2014;9(8):
e106066. doi:10.1371/journal.pone.0106066.eCollection2014.
81. Brandt C, Pedersen BK. The role of exercise-induced myokines in muscle
homeostasis and the defense against chronic diseases. J Biomed Biotechnol.
2010;(in press)
82. Pedersen BK. IL-6 signaling in exercise and disease. Biochem Soc Trans.
2007;35:1295–7.
83. Febbraio MA, Pedersen BK. Contraction-induced myokine production
and release: is skeletal muscle an endocrine organ? Exerc Sport Sci Rev.
2005;33:114–9.
84. Machado M, Koch AJ, Willardson JM, Pereira LS, Cardoso MI, Motta MK, et al.
Effect of varying rest intervals between sets of assistance exercises on
creatine kinase and lactate dehydrogenase responses. J Strength Cond Res.
2011;25:1339–45.
85. Emerson NS, Fukuda DH, Stout JR, Robinson 4th EH, McCormack WP,
Scanlon TC, et al. Physical working capacity at fatigue threshold (PWCFT) is
associated with sarcopenia-related body composition and measures of
functionality in older adults. Arch Gerontol Geriatr. 2014;59:300–4.
86. deVries HA, Brodowicz GR, Robertson LD, Svoboda MD, Schendel JS, Tichy
AM, et al. Estimating physical working capacity and training changes in the
elderly at the fatigue threshold (PWCft). Ergonomics. 1989;32:967–77.
87. Snell PG, Mitchell JH. The role of maximal oxygen uptake in exercise
performance. Clin Chest Med. 1984;5:51–62.
88. Smith-Ryan AE, Woessner MN, Melvin MN, Wingfield HL, Hackney AC. The
effects of beta-alanine supplementation on physical working capacity at
heart rate threshold. Clin Physiol Funct Imaging. 2014;34:397–404.
89. Makrides L, Heigenhauser GJ, McCartney N, Jones NL. Maximal short term
exercise capacity in healthy subjects aged 15–70 years. Clin Sci (Lond).
1985;69:197–205.
90. Grassi B, Porcelli S, Salvadego D, Zoladz JA. Slow VO2 kinetics during
moderate-intensity exercise as markers of lower metabolic stability and
lower exercise tolerance. Eur J Appl Physiol. 2011;111:345–55.
91. Chen SW, Liaw JW, Chan HL, Chang YJ, Ku CH. A real-time fatigue
monitoring and analysis system for lower extremity muscles with cycling
movement. Sensors (Basel). 2014;14:12410–24. doi:10.3390/s140712410.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Finsterer and Drory BMC Musculoskeletal Disorders  (2016) 17:40 Page 13 of 13
